awmsg logo

Clinical Effectiveness Prescribing Programme (CEPP)

National Prescribing Indicators

National Prescribing Indicators are developed annually to promote rational prescribing, balancing both quality and cost. The indicators are evidence-based and are designed to be clear and applicable at practice level.

National Prescribing Indicators 2017–2018
National Prescribing Indicators 2016–2017
National Prescribing Indicators 2015–2016
National Prescribing Indicators 2014–2015

National Prescribing Indicators 2013–2014

National Prescribing Indicators 2012–2013
National Prescribing Indicators 2011–2012


The Supporting Information for Prescribers summarises the AWMSG NPIs and provides points for consideration and links to supporting materials.

National Prescribing Indicators 2017–2018: Supporting Information for Prescribers
National Prescribing Indicators 2016–2017: Supporting Information for Prescribers
National Prescribing Indicators 2015–2016: Supporting Information for Prescribers
National Prescribing Indicators 2014–2015: Supporting Information for Prescribers
National Prescribing Indicators 2013–2014: Supporting Information for Prescribers

A slide set has been produced to support the National Prescribing Indicators 2015-2016, and is available here as a PowerPoint presentation for local adaption.

National Prescribing Indicators 2017-2018 - Slide Set
National Prescribing Indicators 2016-2017 - Slide Set
National Prescribing Indicators 2015-2016 - Slide Set

Secondary Care National Prescribing Indicators have been developed to highlight therapeutic priorities for
NHS Wales in secondary care.

Secondary Care National Prescribing Indicators 2016–2017

National Prescribing Indicator Analysis

For each National Prescribing Indicator the threshold is set at the 75th percentile (i.e. reducing or increasing prescribing rates in line with the best performing 25% of practices).  All practices within Health Boards are encouraged to achieve or move towards these thresholds. The following analyses of prescribing data are available:

Indicator-specific reports
National Prescribing Indicators: Analysis of Antibacterial Prescribing Data to March 2014
National Prescribing Indicators: Analysis of Yellow Card Reporting Data to December 2013
National Prescribing Indicators: Analysis of Morphine and Tramadol Data to June 2013
National Prescribing Indicators: Analysis of Antidepressant and Dosulepin Prescribing Data to December 2012

Quarterly reports

National Prescribing Indicators 2016-2017: Analysis of Prescribing Data to December 2016
National Prescribing Indicators 2016-2017: Analysis of Prescribing Data to September 2016
National Prescribing Indicators 2016-2017: Analysis of Prescribing Data to June 2016

National Prescribing Indicators 2015-2016: Analysis of Prescribing Data to March 2016 (Annual Primary Care Prescribing Report)
National Prescribing Indicators 2015-2016: Analysis of Prescribing Data to December 2015
National Prescribing Indicators 2015-2016: Analysis of Prescribing Data to September 2015
National Prescribing Indicators 2015-2016: Analysis of Prescribing Data to June 2015

National Prescribing Indicators 2014-2015: Analysis of Prescribing Data to March 2015 (Annual Primary Care Prescribing Report)
National Prescribing Indicators 2014-2015: Analysis of Prescribing Data to December 2014
National Prescribing Indicators 2014-2015: Analysis of Prescribing Data to September 2014

National Prescribing Indicators 2014-2015: Analysis of Prescribing Data to June 2014

National Prescribing Indicators 2013-2014: Analysis of Prescribing Data to March 2014
National Prescribing Indicators 2013-2014: Analysis of Prescribing Data to December 2013

National Prescribing Indicators 2013-2014: Analysis of Prescribing Data to September 2013
National Prescribing Indicators 2013-2014: Analysis of Prescribing Data to June 2013

National Prescribing Indicators 2012-2013: Analysis of Prescribing Data to March 2013
National Prescribing Indicators 2012-2013: Analysis of Prescribing Data to December 2012
National Prescribing Indicators 2012-2013: Analysis of Prescribing Data to September 2012

National Prescribing Audits

The following National Prescribing Audits have been developed to highlight prescribing, safety and cost-effectiveness issues.  The audits are intended to support the AWMSG National Prescribing Indicators.

Medicines Management for CKD (February 2017)
Towards Appropriate Non-Steroidal Anti-Inflammatory Drug (NSAID) Prescribing (June 2015)
Focus on Antibiotic Prescribing (June 2015)

Word versions:

  • CEPP National Audit - Antibiotic Prescribing - 1. Sore Throat
  • CEPP National Audit - Antibiotic Prescribing - 2. Acute Rhinosinusitis
  • CEPP National Audit - Antibiotic Prescribing - 3. UTI in Females
  • CEPP National Audit - Antibiotic Prescribing - 4. Acute Cough and Acute Bronchitis
  • CEPP National Audit - Antibiotic Prescribing - 5. Fluoroquinolones
  • CEPP National Audit - Antibiotic Prescribing - 6. Cephalosporins
  • CEPP National Audit - Antibiotic Prescribing - 7. Co-amoxiclav
  • CEPP National Audit - Antibiotic Prescribing - 8. Hospital Prescribing
  • CEPP National Audit - Antibiotic Prescribing - 9. Delayed and Back Up Prescribing
  • CEPP National Audit - Antibiotic Prescribing - 10. Read Coding to Identify HCAI
  • CEPP National Audit - Antibiotic Prescribing - 11. Review Sheet
  • CEPP National Audit - Antibiotic Prescribing - 12 CPD Sheet

    Repeat Prescribing (June 2012)
    Patient Safety: Lithium Prescribing (March 2012)
    Towards More Appropriate Management of Depression in a Primary Care Setting (March 2012)
    Reducing the Use of High Acquisition Cost (HAC) Proton Pump Inhibitors (PPIs) 2011-2013 (March 2011)
    Community Pharmacy Contract All Wales Multi-Disciplinary Audit Proton Pump Inhibitors (PPIs) (March 2011) 

    Therapeutic Priorities and CEPP Summary

    This document summarises the AWMSG therapeutic priorities for the financial year. It also outlines the recommended structure of CEPP and elements within the General Medical Services (GMS) through which prescribing initatives can be progressed.

    Therapeutic Priorities and CEPP Summary 2017-2018
    Therapeutic Priorities and CEPP Summary 2016-2017
    Therapeutic Priorities and CEPP Summary 2015-2016
    Therapeutic Priorities and CEPP Summary 2014-2015